By Dr. Priyom Bose, Ph.D. By reading subtle throat vibrations and pulse signals, a lightweight AI -powered choker helps ...

When David Betts was diagnosed with ALS, he became fixated on finding a tool that could help him keep his voice – but none of them sounded human. “I didn’t know how long I would have my voice,” Betts ...

At the end of the year, Ochsner will open a specialty neuroscience center on its main campus, that will bring together ...

As we age, there is a decrease in the number of neurons in the basal ganglia, cerebellum and spinal cord that can negatively ...

A new study demonstrates the effectiveness of a widely-used eye injection to manage the previously untreatable rare condition, hypotony, in a project by clinical researchers at UCL and Moorfields Eye ...

Myra Vision's Calibreye aqueous shunt for glaucoma patients is designed to provide adjustable and reversible outflow control.

Currently, the MyoRegulator® device is under investigation as a non-invasive treatment for ALS in a second and larger clinical trial, the CALM ( C ontrolling A myotrophic L ateral Sclerosis M otor ...

The ADAPT trial involves 70 refractory glaucoma patients, focusing on a 12-month primary effectiveness endpoint to evaluate the Calibreye TGT Surgical System. The Calibreye system is the first ...

At 71 years old, facing a terminal diagnosis, Colorado resident Tom Pringle has one more thing he wants to do before he dies: help other people in similar situations by trying an experimental drug to ...

The TikTok star, 37, was officially diagnosed with the terminal neurodegenerative disease in 2022 ...